Matthew McManus - 01 Feb 2025 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
President - DGS
Signature
/s/ Andrew Nick as Attorney-in-Fact for Matthew McManus pursuant to Power of Attorney previously filed.
Issuer symbol
TECH
Transactions as of
01 Feb 2025
Net transactions value
-$120,769
Form type
4
Filing time
04 Feb 2025, 17:31:03 UTC
Previous filing
03 Feb 2025
Next filing
19 Aug 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Options Exercise $0 +4,620 $0.000000 4,620 01 Feb 2025 Direct
transaction TECH Common Stock Tax liability $120,769 -1,642 -36% $73.55 2,978 01 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Restricted Stock Units Options Exercise $0 -4,620 -33% $0.000000 9,241 01 Feb 2025 Common Stock 4,620 Direct F1, F3
holding TECH Performance Restricted Stock Units 2,888 01 Feb 2025 Common Stock 2,888 Direct F1, F2
holding TECH Performance Stock Option (Right to Buy) 7,951 01 Feb 2025 Common Stock 7,951 $68.54 Direct F2
holding TECH Stock Option (Right to Buy) 15,902 01 Feb 2025 Common Stock 15,902 $68.54 Direct F4
holding TECH Performance Restricted Stock Units 15,825 01 Feb 2025 Common Stock 15,825 Direct F1, F5
holding TECH Restricted Stock Units 7,912 01 Feb 2025 Common Stock 7,912 Direct F1, F6
holding TECH Stock Option (Right to Buy) 21,320 01 Feb 2025 Common Stock 21,320 $74.91 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2 Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F3 4,620 restricted stock units vest on 2/1/2025 and 2/1/2027, and 4,621 restricted stock units vest on 2/1/2026.
F4 Options to purchase 3,976 shares vest on 2/1/2025 and 2/1/2027, and options to purchase 3,975 shares vest on 2/1/2026 and 2/1/2028.
F5 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F6 2,637 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 2,638 restricted stock units vest on 8/15/2027.
F7 Options to purchase 5,330 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.